---
title: "iBio Announces Pricing of $50 Million Public Offering"
description: "SAN DIEGO, Aug. 19, 2025 ( GLOBE NEWSWIRE ) -- iBio, Inc. ( Nasdaq: IBIO ) , an AI-driven innovator of precision antibody therapies, today announced the pricing of an underwritten public offering ( th"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/253652806.md"
published_at: "2025-08-19T13:11:35.000Z"
---

# iBio Announces Pricing of $50 Million Public Offering

> SAN DIEGO, Aug. 19, 2025 ( GLOBE NEWSWIRE ) -- iBio, Inc. ( Nasdaq: IBIO ) , an AI-driven innovator of precision antibody therapies, today announced the pricing of an underwritten public offering ( the "offering" ) of ( i ) pre-funded warrants to purchase 71,540,000 shares of iBio's common stock ...

SAN DIEGO, Aug. 19, 2025 ( GLOBE NEWSWIRE ) -- iBio, Inc. ( Nasdaq: IBIO ) , an AI-driven innovator of precision antibody therapies, today announced the pricing of an underwritten public offering ( the "offering" ) of ( i ) pre-funded warrants to purchase 71,540,000 shares of iBio's common stock ...

### Related Stocks

- [IBIO.US - iBio](https://longbridge.com/en/quote/IBIO.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| iBio Announces Private Placement to Fund Pipeline Expansion | iBio, Inc. has announced a private placement to raise approximately $26 million by selling 1,408,481 common shares and p | [Link](https://longbridge.com/en/news/272329206.md) |
| iBio announces private placement financing to raise ~$26M | iBio (IBIO) has announced a private placement financing to raise approximately $26 million through a securities purchase | [Link](https://longbridge.com/en/news/272079227.md) |
| iBio Inc. reports Q2 research and development expenses of USD 4.28 million | iBio Inc. reported Q2 financial results with zero revenue and R&D expenses of $4.28 million. For the six months ending D | [Link](https://longbridge.com/en/news/275509977.md) |
| iBio Inc. Held Annual Shareholder Meeting | iBio Inc. held its Annual Meeting of Stockholders on November 20, 2025. Stockholders elected Dr. Martin Brenner and Dr.  | [Link](https://longbridge.com/en/news/266931236.md) |
| iBio Inc expected to post a loss of 10 cents a share - Earnings Preview | iBio Inc is expected to report a loss of 10 cents per share and a quarterly revenue of $25,000 for the period ending Sep | [Link](https://longbridge.com/en/news/264887883.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.